Suchergebnisse - "Nicholas, Jacqueline"

PubPharm (13)

1

Associations of sNfL with clinico-radiological measures in a large MS population

enthalten in: Annals of clinical and translational neurology | 2023

von Sotirchos, E. | Fitzgerald, K. | Singh, C. | +20

CommentIn: Nat Rev Neurol. 2023 Jan;19(1):3. - PMID 36477431

2

A promising cognitive screener in multiple sclerosis : The NIH toolbox cognition battery concords with gold standard neuropsychological measures

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Manglani, H. | Fisher, M. | Duraney, E. | +2

3

Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Hauser, S. | Cross, A. | Winthrop, K. | +17

4

Employing Connectome-Based Models to Predict Working Memory in Multiple Sclerosis

enthalten in: Brain connectivity | 2022

von Manglani, H. | Fountain-Zaragoza, S. | Shankar, A. | +2

5

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA) : a randomised, controlled, open-label, phase 3b trial

enthalten in: The Lancet. Neurology | 2022

von Foley, J. | Defer, G. | Ryerson, L. | +98

CommentIn: Lancet Neurol. 2022 Jul;21(7):579-581. - PMID 35483388

6

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Cohen, J. | Bermel, R. | Grossman, C. | +13

7

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Bar-Or, A. | Wiendl, H. | Montalban, X. | +30

8

Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2021

von Weber, M. | Nicholas, J. | Yeaman, M.

9

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

enthalten in: Advances in therapy | 2021

von Nicholas, J. | Zhou, H. | Deshpande, C.

10

Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis

enthalten in: Health psychology : official journal of the Division of Health Psychology, American Psychological Association | 2015

von Schirda, B. | Nicholas, J. | Prakash, R.